241 related articles for article (PubMed ID: 29766242)
1. Inactivation of deubiquitinase CYLD enhances therapeutic antibody production in Chinese hamster ovary cells.
Lu Y; Zhou Q; Han Q; Wu P; Zhang L; Zhu L; Weaver DT; Xu C; Zhang B
Appl Microbiol Biotechnol; 2018 Jul; 102(14):6081-6093. PubMed ID: 29766242
[TBL] [Abstract][Full Text] [Related]
2. MiR-106b promotes therapeutic antibody expression in CHO cells by targeting deubiquitinase CYLD.
Xu C; Han Q; Zhou Q; Zhang L; Wu P; Lu Y; Si Y; Ma T; Ma B; Zhang B
Appl Microbiol Biotechnol; 2019 Sep; 103(17):7085-7095. PubMed ID: 31292678
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives.
Lee JS; Grav LM; Lewis NE; Faustrup Kildegaard H
Biotechnol J; 2015 Jul; 10(7):979-94. PubMed ID: 26058577
[TBL] [Abstract][Full Text] [Related]
4. CYLD destabilizes NoxO1 protein by promoting ubiquitination and regulates prostate cancer progression.
Haq S; Sarodaya N; Karapurkar JK; Suresh B; Jo JK; Singh V; Bae YS; Kim KS; Ramakrishna S
Cancer Lett; 2022 Jan; 525():146-157. PubMed ID: 34742871
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of GDP-fucose transporter gene (Slc35c1) in CHO cells by ZFNs, TALENs and CRISPR-Cas9 for production of fucose-free antibodies.
Chan KF; Shahreel W; Wan C; Teo G; Hayati N; Tay SJ; Tong WH; Yang Y; Rudd PM; Zhang P; Song Z
Biotechnol J; 2016 Mar; 11(3):399-414. PubMed ID: 26471004
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD.
Song H; Li D; Wu T; Xie D; Hua K; Hu J; Deng X; Ji C; Deng Y; Fang L
BMB Rep; 2018 Nov; 51(11):602-607. PubMed ID: 30269739
[TBL] [Abstract][Full Text] [Related]
7. miRNA engineering of CHO cells facilitates production of difficult-to-express proteins and increases success in cell line development.
Fischer S; Marquart KF; Pieper LA; Fieder J; Gamer M; Gorr I; Schulz P; Bradl H
Biotechnol Bioeng; 2017 Jul; 114(7):1495-1510. PubMed ID: 28262952
[TBL] [Abstract][Full Text] [Related]
8. miR-182 controls cell growth in gastrointestinal stromal tumors by negatively regulating CYLD expression.
Ling T; Yu F; Cao H
Oncol Rep; 2018 Dec; 40(6):3705-3713. PubMed ID: 30542706
[TBL] [Abstract][Full Text] [Related]
9. Cylindromatosis Is Required for Survival of a Subset of Melanoma Cells.
La T; Jin L; Liu XY; Song ZH; Farrelly M; Feng YC; Yan XG; Zhang YY; Thorne RF; Zhang XD; Teng L
Oncol Res; 2020 Sep; 28(4):385-398. PubMed ID: 32252875
[TBL] [Abstract][Full Text] [Related]
10. CYLD Inhibits the Development of Skin Squamous Cell Tumors in Immunocompetent Mice.
Alameda JP; García-García VA; López S; Hernando A; Page A; Navarro M; Moreno-Maldonado R; Paramio JM; Ramírez Á; García-Fernández RA; Casanova ML
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201751
[TBL] [Abstract][Full Text] [Related]
11. Stable microRNA expression enhances therapeutic antibody productivity of Chinese hamster ovary cells.
Strotbek M; Florin L; Koenitzer J; Tolstrup A; Kaufmann H; Hausser A; Olayioye MA
Metab Eng; 2013 Nov; 20():157-66. PubMed ID: 24144501
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of SIRT6 alleviates apoptosis and enhances cell viability and monoclonal antibody expression in CHO-K1 cells.
Hashemi N; Tabatabaee SH; Shams F; Rahimpour A; Kazemi B; Rajabibazl M; Ranjbari J
Mol Biol Rep; 2023 Jul; 50(7):6019-6027. PubMed ID: 37286776
[TBL] [Abstract][Full Text] [Related]
13. Improving Antibody Production in Stably Transfected CHO Cells by CRISPR-Cas9-Mediated Inactivation of Genes Identified in a Large-Scale Screen with Chinese Hamster-Specific siRNAs.
Lin PC; Liu R; Alvin K; Wahyu S; Murgolo N; Ye J; Du Z; Song Z
Biotechnol J; 2021 Mar; 16(3):e2000267. PubMed ID: 33079482
[TBL] [Abstract][Full Text] [Related]
14. Catalytic domain mutation in CYLD inactivates its enzyme function by structural perturbation and induces cell migration and proliferation.
Johari T; Maiti TK
Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):2081-2089. PubMed ID: 29807073
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of LEF1 Impairs Myeloma Cell Growth Through Modulating CYLD/NF-κB Signaling.
Zhang G; Miao F; Liu K; Wu J; Xu J
Technol Cancer Res Treat; 2021; 20():15330338211034270. PubMed ID: 34269120
[TBL] [Abstract][Full Text] [Related]
16. Ectopic expression of human mTOR increases viability, robustness, cell size, proliferation, and antibody production of chinese hamster ovary cells.
Dreesen IA; Fussenegger M
Biotechnol Bioeng; 2011 Apr; 108(4):853-66. PubMed ID: 21404259
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of microRNAs enhances recombinant protein production in Chinese hamster ovary cells.
Loh WP; Loo B; Zhou L; Zhang P; Lee DY; Yang Y; Lam KP
Biotechnol J; 2014 Sep; 9(9):1140-51. PubMed ID: 24819042
[TBL] [Abstract][Full Text] [Related]
18. Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells.
Figueroa B; Ailor E; Osborne D; Hardwick JM; Reff M; Betenbaugh MJ
Biotechnol Bioeng; 2007 Jul; 97(4):877-92. PubMed ID: 17099908
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Biosynthesis Performance of Heterologous Proteins in CHO-K1 Cells Using CRISPR-Cas9.
Wang W; Zheng W; Hu F; He X; Wu D; Zhang W; Liu H; Ma X
ACS Synth Biol; 2018 May; 7(5):1259-1268. PubMed ID: 29683658
[TBL] [Abstract][Full Text] [Related]
20. One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment.
Grav LM; Lee JS; Gerling S; Kallehauge TB; Hansen AH; Kol S; Lee GM; Pedersen LE; Kildegaard HF
Biotechnol J; 2015 Sep; 10(9):1446-56. PubMed ID: 25864574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
